Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Direct Estimation of HDL-Mediated Cholesterol Efflux Capacity from Serum.

Kuusisto S, Holmes MV, Ohukainen P, Kangas AJ, Karsikas M, Tiainen M, Perola M, Salomaa V, Kettunen J, Ala-Korpela M.

Clin Chem. 2019 Aug;65(8):1042-1050. doi: 10.1373/clinchem.2018.299222. Epub 2019 Apr 17.

PMID:
30996052
2.

Proof of concept for quantitative urine NMR metabolomics pipeline for large-scale epidemiology and genetics.

Tynkkynen T, Wang Q, Ekholm J, Anufrieva O, Ohukainen P, Vepsäläinen J, Männikkö M, Keinänen-Kiukaanniemi S, Holmes MV, Goodwin M, Ring S, Chambers JC, Kooner J, Järvelin MR, Kettunen J, Hill M, Davey Smith G, Ala-Korpela M.

Int J Epidemiol. 2019 Jan 25. doi: 10.1093/ije/dyy287. [Epub ahead of print]

3.

Increased mesenchymal podoplanin expression is associated with calcification in aortic valves.

Näpänkangas J, Ohtonen P, Ohukainen P, Weisell J, Väisänen T, Peltonen T, Taskinen P, Rysä J.

Cardiovasc Pathol. 2019 Mar - Apr;39:30-37. doi: 10.1016/j.carpath.2018.11.006. Epub 2018 Dec 7.

PMID:
30616084
4.

Cellular Mechanisms of Valvular Thickening in Early and Intermediate Calcific Aortic Valve Disease.

Ohukainen P, Ruskoaho H, Rysa J.

Curr Cardiol Rev. 2018;14(4):264-271. doi: 10.2174/1573403X14666180820151325. Review.

PMID:
30124158
5.

Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction.

Kinnunen SM, Tölli M, Välimäki MJ, Gao E, Szabo Z, Rysä J, Ferreira MPA, Ohukainen P, Serpi R, Correia A, Mäkilä E, Salonen J, Hirvonen J, Santos HA, Ruskoaho H.

Sci Rep. 2018 Mar 15;8(1):4611. doi: 10.1038/s41598-018-22830-8.

6.

Targeting vasoactive peptides for managing calcific aortic valve disease.

Peltonen T, Ohukainen P, Ruskoaho H, Rysä J.

Ann Med. 2017 Feb;49(1):63-74. doi: 10.1080/07853890.2016.1231933. Epub 2016 Nov 3. Review.

PMID:
27585243
7.

Mitogen-activated protein kinase p38 target regenerating islet-derived 3γ expression is upregulated in cardiac inflammatory response in the rat heart.

Säkkinen H, Aro J, Kaikkonen L, Ohukainen P, Näpänkangas J, Tokola H, Ruskoaho H, Rysä J.

Physiol Rep. 2016 Oct;4(20). pii: e12996. Epub 2016 Oct 24.

8.

Expression and Localization of Granzymes and Perforin in Human Calcific Aortic Valve Disease.

Ohukainen P, Näpäkangas J, Ohtonen P, Ruskoaho H, Taskinen P, Peltonen T, Rysä J.

J Heart Valve Dis. 2015 Sep;24(5):612-20.

PMID:
26897841
9.

MicroRNA-125b and chemokine CCL4 expression are associated with calcific aortic valve disease.

Ohukainen P, Syväranta S, Näpänkangas J, Rajamäki K, Taskinen P, Peltonen T, Helske-Suihko S, Kovanen PT, Ruskoaho H, Rysä J.

Ann Med. 2015;47(5):423-9. doi: 10.3109/07853890.2015.1059955. Epub 2015 Jul 30.

PMID:
26203686
10.

The Early-Onset Myocardial Infarction Associated PHACTR1 Gene Regulates Skeletal and Cardiac Alpha-Actin Gene Expression.

Kelloniemi A, Szabo Z, Serpi R, Näpänkangas J, Ohukainen P, Tenhunen O, Kaikkonen L, Koivisto E, Bagyura Z, Kerkelä R, Leosdottir M, Hedner T, Melander O, Ruskoaho H, Rysä J.

PLoS One. 2015 Jun 22;10(6):e0130502. doi: 10.1371/journal.pone.0130502. eCollection 2015.

11.

WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function.

Moilanen AM, Rysä J, Kaikkonen L, Karvonen T, Mustonen E, Serpi R, Szabó Z, Tenhunen O, Bagyura Z, Näpänkangas J, Ohukainen P, Tavi P, Kerkelä R, Leósdóttir M, Wahlstrand B, Hedner T, Melander O, Ruskoaho H.

PLoS One. 2015 Apr 27;10(4):e0124907. doi: 10.1371/journal.pone.0124907. eCollection 2015.

12.

Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice.

Tolonen AM, Magga J, Szabó Z, Viitala P, Gao E, Moilanen AM, Ohukainen P, Vainio L, Koch WJ, Kerkelä R, Ruskoaho H, Serpi R.

Pharmacol Res Perspect. 2014 Aug;2(4):e00056. doi: 10.1002/prp2.56. Epub 2014 Jun 12.

13.

In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart.

Tölli MA, Ferreira MP, Kinnunen SM, Rysä J, Mäkilä EM, Szabó Z, Serpi RE, Ohukainen PJ, Välimäki MJ, Correia AM, Salonen JJ, Hirvonen JT, Ruskoaho HJ, Santos HA.

Biomaterials. 2014 Sep;35(29):8394-405. doi: 10.1016/j.biomaterials.2014.05.078. Epub 2014 Jun 28.

PMID:
24985734
14.

If the wheel ain't broke, don't reinvent it.

Ohukainen P.

Lipids Health Dis. 2013 Apr 11;12:51. doi: 10.1186/1476-511X-12-51.

15.

Statin treatment and gene expression of anti-atherogenic factor C-type natriuretic peptide system in stenotic aortic valves.

Peltonen T, Ohtonen P, Näpänkangas J, Ohukainen P, Ruskoaho H, Taskinen P.

J Heart Valve Dis. 2011 Sep;20(5):545-51.

PMID:
22066359
16.

Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves.

Pohjolainen V, Mustonen E, Taskinen P, Näpänkangas J, Leskinen H, Ohukainen P, Peltonen T, Aro J, Juvonen T, Satta J, Ruskoaho H, Rysä J.

Atherosclerosis. 2012 Jan;220(1):66-71. doi: 10.1016/j.atherosclerosis.2011.10.003. Epub 2011 Oct 12.

PMID:
22035575

Supplemental Content

Loading ...
Support Center